Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,447,123
  • Shares Outstanding, K 33,647
  • Annual Sales, $ 1,142 M
  • Annual Income, $ 181,850 K
  • 60-Month Beta 1.53
  • Price/Sales 3.93
  • Price/Cash Flow 23.68
  • Price/Book 7.41
Trade MEDP with:

Options Overview Details

View History
  • Implied Volatility 46.45% ( -2.34%)
  • Historical Volatility 50.27%
  • IV Percentile 68%
  • IV Rank 43.43%
  • IV High 71.38% on 04/25/22
  • IV Low 27.32% on 08/27/21
  • Put/Call Vol Ratio 0.07
  • Today's Volume 62
  • Volume Avg (30-Day) 103
  • Put/Call OI Ratio 1.73
  • Today's Open Interest 2,838
  • Open Int (30-Day) 3,346

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 1.33
  • Number of Estimates 3
  • High Estimate 1.39
  • Low Estimate 1.29
  • Prior Year 1.06
  • Growth Rate Est. (year over year) +25.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.94 +6.77%
on 04/27/22
143.96 -5.85%
on 05/04/22
+2.94 (+2.22%)
since 04/26/22
3-Month
126.94 +6.77%
on 04/27/22
171.57 -21.00%
on 04/04/22
-17.72 (-11.56%)
since 02/25/22
52-Week
126.94 +6.77%
on 04/27/22
231.00 -41.32%
on 11/19/21
-30.35 (-18.30%)
since 05/26/21

Most Recent Stories

More News
Walgreens Boots (WBA) Omnichannel Aids Growth Amid Cost Woes

The continued acceleration of Walgreens' (WBA) omnichannel offerings and a significant rise in MyWalgreens membership are notable upsides in recent times.

MASI : 139.34 (+1.11%)
AMN : 93.75 (+2.18%)
WBA : 43.04 (+1.37%)
MEDP : 135.54 (+2.55%)
Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now

Investors are optimistic about Myriad Genetics (MYGN) owing to strong Q1 2022 results and growth in testing volumes.

UNH : 502.23 (+0.83%)
ALKS : 29.36 (+1.77%)
MYGN : 21.15 (-0.52%)
MEDP : 135.54 (+2.55%)
Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVI

Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.

ILMN : 243.57 (+0.48%)
MASI : 139.34 (+1.11%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)
Here's Why You Should Retain Amedisys (AMED) Stock for Now

Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.

UNH : 502.23 (+0.83%)
AMED : 117.39 (+2.12%)
ALKS : 29.36 (+1.77%)
MEDP : 135.54 (+2.55%)
What's in Store for Canopy Growth (CGC) in Q4 Earnings?

Product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to have driven Canopy Growth's (CGC) Q4 top line.

MASI : 139.34 (+1.11%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)
CGC : 5.55 (+10.34%)
IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern

Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.

UNH : 502.23 (+0.83%)
IDXX : 384.92 (+4.64%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)
Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable

Abbott's (ABT) study data presented at EuroPCR 2022 reinforces the company's commitment to offering structural heart solutions, supported by clinical evidence that exceeds existing standards of care.

ABT : 114.87 (+1.48%)
UNH : 502.23 (+0.83%)
ALKS : 29.36 (+1.77%)
MEDP : 135.54 (+2.55%)
Thermo Fisher (TMO) to Advance Precision Medicine in Qatar

Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.

TMO : 540.11 (+1.09%)
MASI : 139.34 (+1.11%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)
Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger

Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.

UNH : 502.23 (+0.83%)
ILMN : 243.57 (+0.48%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)
Here's Why Investors Should Retain Haemonetics (HAE) For Now

Investors are optimistic about Haemonetics's (HAE) better-than-expected results and robust segmental performance.

UNH : 502.23 (+0.83%)
HAE : 62.27 (-0.43%)
AMN : 93.75 (+2.18%)
MEDP : 135.54 (+2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 141.13
2nd Resistance Point 138.79
1st Resistance Point 137.17
Last Price 135.54
1st Support Level 133.21
2nd Support Level 130.87
3rd Support Level 129.25

See More

52-Week High 231.00
Fibonacci 61.8% 191.25
Fibonacci 50% 178.97
Fibonacci 38.2% 166.69
Last Price 135.54
52-Week Low 126.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar